Results 1 to 10 of about 129,223 (217)
International Journal of Basic & Clinical Pharmacology, 2022 Background: The aim was to analyze the percentage cost variations among different brands of the commonly prescribed anti-retroviral agents in the treatment of human immunodeficiency virus.Methods: The cost of different brands of commonly used Anti-Retroviral agents was sorted out by referring latest Indian drug index online, drug today, current index ...
Anusha R., Geetha A.
openaire +3 more sources
Pharmacogenetics of antiretroviral drugs [PDF]
Vojnosanitetski Pregled, 2012 nema
Dragović Gordana +2 more
doaj +1 more source
Adherence to HIV post-exposure prophylaxis in a specialized service in São Paulo, Brazil
Journal of Infection in Developing Countries, 2023 Introduction: The effectiveness of human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) depends on adherence to the protocol, which includes taking antiretrovirals (ARVs) and attending visits.
Marcos Morais Santos Silva +2 more
doaj +1 more source
Einstein (São Paulo), 2021 Objective: To characterize the sociodemographic profile of the population undergoing antiretroviral treatment in the state of Paraná, Brazil, to investigate the proportion of people undergoing treatment among all those diagnosed, and to analyze the ...
Frederico Alves Dias +2 more
doaj +2 more sources
UV Spectrophotometric Method for Assay of the Anti-Retroviral Agent Lamivudine in Active Pharmaceutical Ingredient in its Tablet Formulation [PDF]
Journal of Young Pharmacists, 2010 A rapid, simple, accurate, and economical spectrophotometric method has been developed and validated for the assay of the anti-retroviral agent lamivudine in active pharmaceutical ingredients (API) and in its tablet formulation. The analysis is based on the UV absorbance maxima at about 270nm wavelength of lamivudine, using methanol as solvent.
Deepali, G, Elvis, M
openaire +2 more sources
Bilateral lower limb gangrene due to HIV vasculitis – a rare case
Sri Lankan Journal of Infectious Diseases, 2017 Human immunodeficiency virus (HIV) positive patients may develop vasculitis, either mediated by immunological factors or by direct vascular injury. It may also be caused by infectious agents or by some nonspecific causes.
D. Majumdar +6 more
doaj +1 more source
Cadernos de Saúde Pública, 2008 O preço elevado de medicamentos patenteados tem intensificado o debate em torno do impacto do regime da propriedade intelectual sobre o acesso a tratamentos de saúde, merecendo destaque o caso do HIV/AIDS.
Constance Marie Milward de Azevedo Meiners
doaj +1 more source
Pharmaceuticals, 2023 The human immunodeficiency virus (HIV) is the primary cause of acquired immune deficiency syndrome (AIDS), one of the deadliest pandemic diseases. Various mechanisms and procedures have been pursued to synthesise several anti-HIV agents, but due to the ...
Mustapha Suleiman +8 more
doaj +1 more source
Profile of anti-retroviral agents use in Colombia
Biomédica, 2018 Introducción. La infección por VIH es una pandemia para la que actualmente existe tratamiento farmacológico que puede controlarla y prolongar la expectativa de vida del paciente.Objetivo. Determinar los patrones de prescripción de fármacos antirretrovirales en una población de personas afiliadas al régimen contributivo del Sistema General de Seguridad ...
Machado-Alba, Jorge E. +2 more
openaire +5 more sources
Electrolyte imbalance and sleep problems during anti-retroviral therapy: an under-recognized problem [PDF]
Sleep ScienceHuman immunodeficiency virus (HIV) infection, and the anti-retroviral therapy (ART) associated complications necessitate that the medical care system keeps evolving for proper management of this group of patients.
Md Dilshad Manzar +7 more
doaj +1 more source